These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Comparison between on-demand dosing of dapoxetine alone and dapoxetine plus mirodenafil in patients with lifelong premature ejaculation: prospective, randomized, double-blind, placebo-controlled, multicenter study. Lee WK, Lee SH, Cho ST, Lee YS, Oh CY, Yoo C, Cho JS, Lee SK, Yang DY. J Sex Med; 2013 Nov; 10(11):2832-41. PubMed ID: 23937271 [Abstract] [Full Text] [Related]
5. Baseline characteristics and treatment outcomes for men with acquired or lifelong premature ejaculation with mild or no erectile dysfunction: integrated analyses of two phase 3 dapoxetine trials. Porst H, McMahon CG, Althof SE, Sharlip I, Bull S, Aquilina JW, Tesfaye F, Rivas DA. J Sex Med; 2010 Jun; 7(6):2231-2242. PubMed ID: 20412423 [Abstract] [Full Text] [Related]
8. Perceived control over ejaculation is central to treatment benefit in men with premature ejaculation: results from phase III trials with dapoxetine. Shabsigh R, Patrick DL, Rowland DL, Bull SA, Tesfaye F, Rothman M. BJU Int; 2008 Sep; 102(7):824-8. PubMed ID: 18647300 [Abstract] [Full Text] [Related]
9. Treatment benefit of dapoxetine for premature ejaculation: results from a placebo-controlled phase III trial. Kaufman JM, Rosen RC, Mudumbi RV, Tesfaye F, Hashmonay R, Rivas D. BJU Int; 2009 Mar; 103(5):651-8. PubMed ID: 19021601 [Abstract] [Full Text] [Related]
14. Novel Treatment for Premature Ejaculation in the Light of Currently Used Therapies: A Review. Porst H, Burri A. Sex Med Rev; 2019 Jan 30; 7(1):129-140. PubMed ID: 30057136 [Abstract] [Full Text] [Related]
15. Assessing satisfaction in men with premature ejaculation after dapoxetine treatment in real-world practice. Jiann BP, Huang YJ. Int J Clin Pract; 2015 Nov 30; 69(11):1326-33. PubMed ID: 26194604 [Abstract] [Full Text] [Related]